HK이노엔

195940KOSDAQ의약품 제조업

50.7 / 100

Reference Date: 2026-07-24

Financial Score18.0 / 40

News Sentiment16.7 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is above the industry average but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HK Inoent is a pharmaceutical company primarily engaged in ETC (Specialty Pharmaceuticals) and H&B (Health & Beauty) businesses, achieving sales of 1.632 trillion KRW and operating profit of 110.9 billion KRW in 2025 through key products like K-Cap and H&B items such as Condition. Established in 1984, the company expanded through the acquisition of Hanil Pharm in 2006 and Hanacolma in 2018, focusing on R&D and global market expansion.

Number of Employees

1,723people

Average Salary

84.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

14.52Industry Average 11.233.0Point

Higher than industry avg (caution)

PBR

0.83Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE

5.87Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

13.25Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲29.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 5.0% (improving, 3yr)

Detailed News Sentiment

9 totalPositive 4Neutral 5Negative 0Average Sentiment Score 66.7

Neutral
HK이노엔, 대학생 서포터즈 ‘컨디션 C.R.E.W’ 수료
HK이노엔의 대학생 서포터즈 수료식은 브랜드 인지도 향상에 기여할 것으로 보이나, 직접적인 재무 영향은 제한적입니다.
Neutral
HK이노엔 2분기 실적 ‘숨 고르기’…“케이캡 글로벌 성과가 관건”.....
HK이노엔의 2분기 실적 전망은 컨센서스를 밑돌 것으로 보이나, 글로벌 케이캡 성과와 중국 로열티 확대가 긍정적 요인으로 작용할 것으로 예상됩니다.
Positive
코로나19 백신 484만회분 확보…최신 XFG 변이 대응
HK이노엔 관련 직접적 영향은 없으나, 코로나19 백신 확보로 인한 보건 분야의 긍정적 경제적 효과 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (7%, downtrend)

Current 38,800Won52-week high 57,60052-week low 37,300

1-month return3.0Point

1m 0.26% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral결산실적공시예고2026-07-23
Neutral기업설명회(IR)개최2026-07-02
Neutral주주총회소집결의 (임시주주총회)2026-07-02
Neutral주주명부폐쇄기간또는기준일설정2026-07-02
Neutral주식등의대량보유상황보고서(약식)2026-07-01